Despite the name, most REEs are not particularly rare. They were called “rare-earth elements” because, when they were ...

While the move is couched in the language of national security and non-proliferation compliance, its timing and scope are not ...

China is blocking exports of these vital minerals. What makes them so special?

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Prodigious siblings can be annoying. All too often, they steal the spotlight and cast behind them an infuriating shadow of ...

The radiopharmaceutical lutetium 177 can be used after radium 223 to treat metastatic castration-resistant prostate cancer.

In the PSMAfore trial, Pluvicto reduced the risk of radiographic progression or death by 59%. The Food and Drug Administration (FDA) has expanded the approval of Pluvicto ® (lutetium Lu 177 ...

Curium Pharma has completed its acquisition of Eczacıbaşı-Monrol Nuclear Products Co., enhancing its capacity in nuclear medicine. The acquisition bolsters Curium’s manufacturing capacity for Lutetium ...

Eckert & Ziegler will provide its high-quality non-carrier added Lutetium-177 chloride (n.c.a. Lu-177, Theralugand ®) to support AtomVie's CDMO activities for radiopharmaceutical manufacturing.